Table 2.
Definition of TACE failure/refractoriness by the Japanese Society of Hepatology.
Item | Definition |
---|---|
Intrahepatic lesion | i. Two or more consecutive insufficient responses of the treated tumor (viable lesion > 50%) even after changing the chemotherapeutic agents and/or reanalysis of the feeding artery. The response evaluation is based on CT or MRI at 1–3 months after adequately performed selective TACE. |
ii. Two or more consecutive increases of tumor number even after having changed the chemotherapeutic agents and/ or reanalysis of the feeding artery. The response evaluation is based on CT or MRI at 1–3 months after adequately performed selective TACE. | |
Tumor markers | Continuous elevation of tumor markers after TACE even though transient decrease is observed. |
Vascular invasion | Appearance of vascular invasion |
Metastasis | Appearance of extrahepatic spread |
TACE, transarterial chemoembolization; CT, computed tomography; MRI, magnetic resonance imaging.